New treatments in head and neck cancer.
Kies
Merrill S
MS
University of Texas M. D. Anderson Cancer Center, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D000068818:Cetuximab; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000601:surgery; D006801:Humans
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab